Protein clumps in the brain have long been associated with Alzheimer’s, but other potential causes of the condition are now ...

For the study, the researchers gave the study participants an experimental anti-amyloid drug. They found that 22 participants ...

The first evidence that removing amyloid plaques may delay Alzheimer’s symptoms has now been published. In The Lancet Neurology on March 19, scientists led by Randall Bateman at Washington University ...

Alzheimer’s disease is usually associated with old age. But around 5%-10% of all Alzheimer’s cases occur in people under the age of 65. Early-onset Alzheimer’s disease progresses more rapidly and ...

The EMA has recommended refusing marketing authorization for donanemab, a monoclonal antibody against amyloid beta, in the ...

A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...

The brain's immune cells removed plaques and helped restore a healthier environment in the brains of immunized patients. For over 30 years, scientists have focused on treating Alzheimer’s disease by ...

If you’re in your 30s, 40s or 50s, dementia might feel like a distant concern, something you associate with advanced age.

Research shows experimental anti-amyloid drug reduced cognitive symptom risk by 50% in people with rare genetic mutations ...

Too much build-up of these amyloid plaques in the brains can lead to issues with brain function and is linked to Alzheimer's, per the National Institute on Aging (NIA). But we'll get to more of ...

The latest drugs for Alzheimer's disease may add years of independence to the lives of patients, but possibly only for some.

A study examining the long-term effects of anti-amyloid therapy gantenerumab suggests that full amyloid plaque removal may help reduce Alzheimer’s symptoms in individuals at risk for dominantly ...